Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMH-407 for Influenza in Outpatient Adults
NCT04250311Phase 3Suspended
- Sponsor
- Materia Medica Holding
- Start
- Dec 2019
- Primary completion
- Dec 2024
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing MMH-407 with Placebo (2 arms). Primary endpoint: Time to improvement of influenza symptoms. Started Dec 2019; status: suspended.
02
Drugs
Ergoferon
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04250311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04250311.